Induced Self-Assembly of Vitamin E-Spermine/Sirna Nanocomplexes via Spermine/Helix Groove-Specific Interaction for Efficient Sirna Delivery and Antitumor Therapy.

gene delivery lysosome escape self-assembly siRNA vitamin E

Journal

Advanced healthcare materials
ISSN: 2192-2659
Titre abrégé: Adv Healthc Mater
Pays: Germany
ID NLM: 101581613

Informations de publication

Date de publication:
17 Jan 2024
Historique:
revised: 27 12 2023
received: 21 09 2023
medline: 18 1 2024
pubmed: 18 1 2024
entrez: 18 1 2024
Statut: aheadofprint

Résumé

Gene therapy has been one of potential strategies for the treatment of different diseases, where efficient and safe gene delivery systems are also extremely in need. Current LNP technology highly depends on the packing and condensation of nucleic acids with amine moieties. Here, we attempt to covalently link two natural compounds, spermine and vitamin E, to develop self-assembled nucleic acid delivery systems. Among them, the spermine moieties specifically interact with the major groove of siRNA helix through salt bridge interaction, while vitamin E moieties are located around siRNA duplex. Such amphiphilic vitamin E-spermine/siRNA complexes can further self-assemble into nanocomplexes like multi-blade wheels. Further studies indicate that these siRNA nanocomplexes with the neutrally charged surface of vitamin E can enter cells via caveolin/lipid raft mediated endocytosis pathway and bypass lysosome trapping. With these self-assembled delivery systems, we successfully achieve efficient siRNA delivery for Eg5 and Survivin gene silencing as well as DNA plasmid delivery. Further in vivo study indicate that VE-Su-Sper/DSPE-PEG

Identifiants

pubmed: 38234201
doi: 10.1002/adhm.202303186
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2303186

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Xiaoran Zhao (X)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Qi Xu (Q)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Qian Wang (Q)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

XingXing Liang (X)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Jing Wang (J)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Hongwei Jin (H)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Yizhi Man (Y)

School of Chemistry and Materials Science, Anhui Normal University, Beijing, China.

Dongyang Guo (D)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Feng Gao (F)

School of Chemistry and Materials Science, Anhui Normal University, Beijing, China.

Xinjing Tang (X)

State Key Laboratory of Natural and Biomimetic Drugs and Chemical Biology Center, School of Pharmaceutical Sciences, Peking University, NO. 38, Xueyuan Rd., Beijing, 100191, China.

Classifications MeSH